Azienda Ospedaliera Universitaria Integrata Verona
Clinical trials sponsored by Azienda Ospedaliera Universitaria Integrata Verona, explained in plain language.
-
Real-World cancer care: which drug works better after chemo?
Disease control CompletedThis study looked at how well two different immunotherapy drugs work for people with advanced bladder cancer who had already received chemotherapy. Researchers followed 35 patients in real-world hospital settings to compare Avelumab (given right after chemo) and Pembrolizumab (gi…
Sponsor: Azienda Ospedaliera Universitaria Integrata Verona • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New lens offers hope for clearer vision in complex eye condition
Disease control CompletedThis study tested a special type of lens (the Vivity EDOF IOL) during cataract surgery for people who also have a mild, stable form of keratoconus, a condition that warps the cornea. The goal was to see if this lens could safely provide good vision at near, intermediate, and far …
Phase: NA • Sponsor: Azienda Ospedaliera Universitaria Integrata Verona • Aim: Disease control
Last updated Mar 17, 2026 13:06 UTC
-
Eye study tests new lens combo to reduce annoying halos after cataract surgery
Symptom relief CompletedThis study compared two approaches to cataract surgery lenses to see which gives better vision with fewer side effects like halos and glare. It involved 36 adults who had cataract surgery in both eyes. One group received a different lens in each eye, while the other group got the…
Phase: NA • Sponsor: Azienda Ospedaliera Universitaria Integrata Verona • Aim: Symptom relief
Last updated Mar 09, 2026 14:24 UTC